Fluzoparib increases radiation sensitivity of non-small cell lung cancer (NSCLC) cells without BRCA1/2 mutation, a novel PARP1 inhibitor undergoing clinical trials
暂无分享,去创建一个
Ping Wang | Yue Xu | Q. Wang | G. Ying | Changyong Yang | Jingtao Luo | X. Dai | Hua Hu | Jie Chen | Lujun Zhao | Jifeng Sun | Lianmin Zhang | Shilei Xu | Ningbo Liu | Qian Wang